MULTID ANALYSES AB’s Post

The cell and gene therapy sector is on the rise with record funding, clinical research, and new launches in recent years. Swipe to discover key data points demonstrating this rise, direct from the Institute’s report, Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. If you found this document useful, be sure to follow IQVIA Institute’s LinkedIn page for more insightful information. Already following us? Share this post to spread the word. #DataSciences #Biotech #LifeSciences #Pharma Diego Correa, MD, MSc, PhD Barbara Isquith Arone, MS Rob Glik Adrian McKemey Carolina Ricarte Dan Winkelman Amritha J. Joshi Venugopal Mark Trusheim American Society of Gene & Cell Therapy Alliance for Regenerative Medicine ISCT, International Society for Cell & Gene Therapy

Thorough analysis of current state and future scenarios in cell and gene therapies. #iqvia #cellandgene

Check out the March issue of Cell & Gene Therapy Insights which has some great articles collected by experts as passionate as I am about advancing this field! https://lnkd.in/gVBi92GE

#CTICares: We’re proud to lead the way in cell and gene therapy and share. #CTIFacts regarding our extensive portfolio: - Pioneering Innovation: CTI has been instrumental in the development of some of the world's first approved gene therapy products. We commit to pushing the boundaries of clinical research.   - Trusted Partnerships: With years of experience, CTI has established trusted relationships and deep expertise navigating complex gene therapy regulatory pathways. We’re here to guide and support our partners at every step.  - Dedication to Progress: Did you know approximately 50% of our active trials focus on cell or gene therapy? We're dedicated to advancing groundbreaking research that can transform lives. Our passion for innovation and commitment to #MoveMedicineForward drives us to impact patients and regenerative medicine worldwide.    #MovingMedicineForward #AdvancingHealthcareSolutions #CRO #ThinkGlobalActLocal #ClinicalResearch #LeadershipInTheField #CellandGeneTherapy #CellTherapy #GeneTherapy #RegenerativeMedicine 

Cell and Gene Therapy: $27 Billion in Q1-Q3 2023 Funding — MediaContacts.co — #pin the most extensive examination of #current #cell and #gene #therapy dealmaking, #medical #market #research #publisher Kalorama #Information estimates that the #industry attracted over #27 #billion in #investments throughout the first nine #months of 2023. ARLINGTON, #Va #Dec #12 #2023 The #concepts of cell therapy and gene therapy have been investigated for decades, but there were #major #challenges in the #early #years Through incremental #progress and the gradual introduction of enabling tools such as CRISPR and next-generation sequencing

Thank you Genopole, Université Paris-Saclay, and LBEPS for organizing the 3rd edition of "Innovative and Combinatory Therapies". It was fulfilling to see start-ups and academics focusing on : - Innovation and optimization in Nanomedicine which plays a crucial role in Cell & Gene therapy. This emphasizes the importance of targeted therapies. - Innovation in virus-free gene engineering has the potential to significantly improve access-to-treatment for patients. - Development and upscaling of cost-efficient delivery systems for Cell & Gene therapy. #Nanomedicine #CellTherapy #GeneTherapy #HealthcareInnovation #Biologics #InnovativeTherapies #Genopole #UniversitéParisSaclay #LBEPS

Developing Gene Therapy? Read our review article on gene editing methodologies, delivery technologies, challenges, successes and solutions! https://ow.ly/RLKs50Rq92a #genetherapy #cancertreatment #oncology #tumor #geneediting #GSsolutions

Navigating the Gene Therapy Biomanufacturing Frontier : Embark on a journey through the dynamic landscape of gene therapy biomanufacturing. Explore the latest insights, innovations, and challenges in this evolving field. Read the article here: #GeneTherapy #Biomanufacturing #Innovation #Pharmaceuticals https://bit.ly/3rVKFHY

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness this potential, stakeholders across the CGT ecosystems must collaborate to overcome barriers to delivering life-changing treatment to patients. Kindly invite you to join the virtual event “Technology and Process Advancements in Cell and Gene Therapy Development” - hosted by #thermofisherscientific to engage in a special panel discussion as industry experts discuss the present and future direction of the cell and gene therapy sector through an Asian lens. The discussion will cover topics such as: 🎯 Large scale processing of mesenchymal stem cells (MSC) and T cell immunotherapies 🎯 Integrated, cutting-edge solutions and process advancements that supports end-to-end workflow  🎯 Regulatory considerations in raw material selection from research through commercialization  🎯 Analytical platforms to evaluate the quality, safety, and efficacy of cell-based products Link: https://shorturl.at/bgiFV Time: Mar 20th